“Steve brings strong creative and commercial skills and experience in managing innovation, intellectual property and new product commercialization in all six continents,” said Frindt. “He will guide IGM’s continuing development of next generation radiation-curable materials to meet customers’ needs and broaden market applications.”
Dr. Postle has global responsibility for research and development, applications, and compliance. His long career in the inks and coatings industry includes 16 years in R&D and knowledge management roles at Sun Chemical Corporation, most recently serving as Executive Director of Intellectual Property Assets. Previously, he held a number of international management positions in marketing and R&D for Dexter Corporation, Total S.A. and Ciba A.G. He holds more than 50 first-issue patents in diverse areas including inks, coatings, photographic dyestuffs, color management, security, photovoltaics and imitation stained glass windows. He obtained his bachelor’s, masters and doctorate degrees in organic chemistry from the University of Oxford, England, and completed a Salter’s Institute Research Fellowship in organometallic chemistry at the University of Cambridge. He is a Fellow of the Royal Society of Chemistry and member of the American Chemical Society and Oil & Colour Chemists Association.